Abstract

United States Antimony will report quarterly results on May 14, 2026 Post Market, with the market looking for higher revenue and an inflection in earnings driven by operational normalization and segment execution.

Market Forecast

Based on the company’s prior disclosures and current-quarter projections, the market anticipates revenue of 14.80 million US dollars for the upcoming quarter, implying a 77.79% year-over-year increase. Forecasted adjusted EPS is about 0.01 US dollars per share, a 50.00% year-over-year decline, and EBIT is projected at -2.60 million US dollars, a 288.00% year-over-year contraction; margin forecasts were not provided.

United States Antimony’s main business is anchored in antimony products, which historically comprise the majority of sales and are expected to drive the consolidated top line as production normalizes and sales mix trends hold. The most promising near-term segment remains antimony, which is expected to capture the bulk of the projected 77.79% year-over-year revenue expansion; the company’s adjacent zeolite business offers incremental contribution and mix diversification that may cushion quarterly volatility.

Last Quarter Review

In the previous quarter, United States Antimony delivered 13.03 million US dollars of revenue, up 89.63% year over year, with a gross profit margin of 20.34%; GAAP net profit attributable to the parent company was -0.29 million US dollars, translating to a -2.20% net profit margin, and adjusted EPS was 0.00 US dollars per share, up 100.00% year over year. A notable financial highlight was a 94.00% quarter-on-quarter improvement in net profit, although the figure remained negative.

From a business-mix standpoint, the company’s portfolio skews heavily toward antimony products (approximately 90% of sales), supported by zeolite and a smaller precious-metals contribution. This concentration underscores why execution in the core antimony line is the central determinant of quarterly revenue cadence, while the zeolite line provides complementary cash flow stability and limited growth exposure.

Current Quarter Outlook

Main business: Antimony revenue recovery and margin path

The company’s forecast points to 14.80 million US dollars of revenue for the current quarter, up 77.79% year over year, with antimony expected to remain the principal driver of the top line. The resumption of field operations at Stibnite Hill in Montana on April 2, 2026 supports a return to more consistent production that should feed through to shipments and invoicing for part of the quarter. In addition to the volume contribution, the company’s pricing and customer-delivery mix will likely shape realized revenue per unit and, by extension, gross margin conversion on higher throughput.

Near-term profitability, however, remains the key question given the forecast of -2.60 million US dollars in EBIT and a projected 50.00% year-over-year decline in adjusted EPS to about 0.01 US dollars. The previous quarter’s 20.34% gross margin sets a reference point; whether the company sustains or expands that level will depend on production continuity, yield, reagent and energy inputs, and maintenance scheduling during the quarter. Operating leverage may be limited if labor and overhead were sized for higher throughput, but a clean run-rate at the mill and stable recoveries can still translate incremental revenue into margin stabilization.

Operationally, the company’s focus this quarter appears to be on execution quality and cost containment. Enhanced run-time at Montana, consistent ore feed characteristics, and controlled logistics expenses can counteract pressure from fixed-cost absorption and any lag in downstream charge recoveries. If the company can keep gross margin near the prior quarter’s 20% threshold while delivering the revenue uplift, the gap between EBIT and cash earnings should start to narrow, improving visibility on breakeven dynamics in subsequent periods.

Most promising business: Zeolite as a cash-flow anchor within the portfolio

While the antimony line dominates, the zeolite business continues to offer a stabilizing, adjacent revenue stream that can smooth quarter-on-quarter variability. Historically, zeolite has contributed a high-single-digit share of consolidated revenue, indicating a material, if smaller, role in unit economics and working-capital flow. With operational continuity restored at Montana, the company is positioned to maintain fulfillment reliability that can support repeat orders and pricing discipline in zeolite shipments.

The relevance of zeolite this quarter lies less in outsized growth and more in its capacity to support blended gross margin and cash cycle efficiency. Predictable throughput and lower variability in processing can help offset swings in the antimony line, particularly if the latter experiences episodic maintenance days or ore-feed heterogeneity. As management allocates labor and plant time across product lines, a consistent zeolite run can bolster utilization and maintain baseline contributions to overhead absorption.

Given the projected 77.79% year-over-year increase in consolidated revenue, any incremental lift from zeolite—through expanded orders or improved delivery timing—would be additive to the quarter’s top-line trajectory. If pricing and terms remain stable, zeolite’s contribution can help maintain overall margin stability even if mix shifts toward lower-margin antimony runs in parts of the quarter. This balanced contribution is strategically important while EBIT remains negative in the forecast.

Primary stock-price drivers this quarter: Execution, leadership continuity, and earnings inflection

The appointment of an interim chief financial officer on May 6, 2026 introduces a leadership transition in the finance function at a time when the company is guiding to higher revenue but negative EBIT. Markets will watch for continuity in disclosure quality, cost controls, and cash management initiatives under interim leadership. Clear articulation around working capital, capex cadence, and any incremental efficiency programs can help investors contextualize the projected EBIT loss relative to future quarters.

Operational reliability after the April 2, 2026 restart at Stibnite Hill is the linchpin for meeting the 14.80 million US dollars revenue estimate. Any unplanned downtime or throughput constraints would reduce shipment volume and risk recalibrating top-line expectations. Conversely, sustained run rates and steady recoveries can help the company exit the quarter with a stronger margin profile and build credibility toward sequential improvement.

Finally, earnings inflection signals matter. Despite the forecast negative EBIT and a 50.00% year-over-year decline in adjusted EPS, the prior quarter’s 94.00% quarter-on-quarter improvement in net profit suggests internal momentum off a low base. Investors will be parsing gross margin resilience against higher volume to determine whether the current quarter establishes a platform for a more material profit recovery in the second half, particularly if cost initiatives and operational practices hold.

Analyst Opinions

The balance of published institutional commentary this year tilts bullish: explicitly, one major brokerage reiterated a positive stance and lifted its target, while no tracked bearish calls appeared in the same period. On March 24, 2026, B. Riley raised its price target for the company to 13 US dollars from 11 US dollars and maintained a Buy rating, citing an improving outlook and valuation support. Taking this together, the ratio of bullish to bearish opinions stands at 100% to 0%, indicating a favorable institutional skew.

The bullish case aligns with the company’s forecast for 14.80 million US dollars of revenue in the quarter, up 77.79% year over year, even as EBIT is projected to remain negative and adjusted EPS is guided to around 0.01 US dollars. Positive institutions appear to be emphasizing volume normalization and operating continuity as near-term catalysts for improved earnings power beyond the current quarter’s projected loss profile. In this framework, a steady gross margin near the prior quarter’s 20.34% and an incremental lift in antimony shipments can be sufficient to compress operating losses sequentially, with zeolite contributions smoothing the revenue and cost base.

Bullish views also factor in the practical implications of leadership continuity during the interim CFO period announced on May 6, 2026. While management transitions can introduce uncertainty, the appointment preserves day-to-day finance oversight, and the anticipated return of the prior CFO after a temporary leave offers an additional continuity marker. If capital allocation discipline and disclosure practices remain intact, the market’s tolerance for a negative-EBIT quarter may persist, provided the top-line trajectory and operating cadence are tracking to the company’s guidance.

Moreover, the April 2, 2026 operational restart at Stibnite Hill in Montana provides a concrete narrative for revenue delivery against the quarter’s guidance. At a minimum, this supports the consensus that higher throughput offsets the drag from fixed costs and one-off weather disruptions seen previously. If realized, the current quarter may be remembered less for the headline negative EBIT and more for demonstrating that revenue and gross margin can sustain a path toward break-even, which underpins the upgraded price target rationale and a constructive stance on the stock’s near-term direction.

In summary, the predominant institutional view is supportive of United States Antimony’s near-term setup: higher revenue, a clearer line of sight on operational cadence, and manageable near-term losses. The key to validating the bullish thesis is delivery against the 14.80 million US dollars revenue estimate and protecting gross margin around the 20% zone, which together would lay groundwork for improved earnings quality in subsequent quarters. Under that scenario, the company’s guidance trajectory and process reliability would justify continued positive coverage and potential upside calibration in forward estimates.